- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05781646
Xpert MTB/RIF Assay for Diagnosis of Tuberculous Meningitis (TBM) in Maharaj Nakorn Chiang Mai Hospital
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Tuberculous meningitis (TBM) was the most serious manifestation of Mycobacterium tuberculosis infection with high rates of morbidity and mortality if treatment is delayed, especially in HIV-infected patients. The fatality rates increased to 60 percent compared to about one third in non-HIV infection. Prevalence and incidence of TBM worldwide is unclear. In 2015, the incidences of TBM were approximately 6-10 percent. In Northern Thailand, from the national survey programs, the prevalence rates of TBM were about 9.7 per 100,000 people, and TBM was the most common cause of death in extra-pulmonary TB patients with mortality rates about 0.54 per 100,000 people. However, these may be underreported due to diagnostic problems.
Prompt and accurate diagnoses with early treatments, were the key elements to reduce deaths and disabilities in TBM. However, there were some major obstacles in the diagnostic procedures concerning the limitations, such as low sensitivity in conventional acid-fast bacilli (AFB) microscopy staining techniques or long turnaround times in gold-standard culture. Therefore, the delays in diagnoses lead to late managements and increased mortalities in TBM, especially in multidrug-resistance (MDR) cases. In the past, a lot of studies tried to solve these problems urgently, but the low frequency of confirmed cases and the absence of a consensus clinical case definition were the huge barriers causing a lack of progression in new clinical trials. In 2010, a uniform clinical case definition for use in clinical research about TBM was established. They used criteria from clinical characteristics, cerebrospinal fluid (CSF) examinations, neuroimaging studies, and evidence of tuberculosis elsewhere. Additionally, microbiological or pathological proof was used to classify the patients who had signs and symptoms of meningitis and were defined as definite, probable, possible, and not tuberculous meningitis. Since then, many clinical studies about TBM diagnosis were developed and made more convenient.
The Xpert MTB/RIF assay was the closed-cartridge-based system heminested PCR for the diagnosis of tuberculosis (TB), and detecting the rifampicin resistant gene in sputum and the CSF. This can be used as a marker for MDR-TB, focused on endemic areas and HIV coinfection. This test has better diagnostic threshold levels (80-100 cfu/ml) than the 5,000 cfu/ml in AFB microscopy staining techniques, shorter duration for the results than conventional TB cultures, and more simplification than nucleic-acid amplification tests. Many studies about the diagnostic accuracy revealed that sensitivity and specificity of this new test varied from 50-86 % and 94-98 % depended on method, population, and laboratory techniques. There were some discussions about the application practicality in the diagnosis of TBM, such as in a large-population study in Vietnam that questioned the lower sensitivity and cost-effectiveness compared with conventional staining and culture. Subsequently, this newer rapid test was approved by WHO for TBM diagnosis.
In Thailand, one of the countries with a high burden of tuberculosis, despite many advantages, use of this test was limited in CSF specimens due to the lack of data, including accuracy in CSF specimens for TBM diagnosis among the Thai population. This study aims to prospectively find out the diagnostic performance and accuracy of Xpert MTB/RIF in CSF samples from patients who presented with subacute lymphocytic meningitis in Northern Thailand, which can be the database for extending the study to cover patients in other parts of Thailand.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Presence of meningitis symptoms and signs including one or more of the following: headache, irritability, vomiting, fever, neck stiff ness, convulsions, focal neurological deficits, altered consciousness, or lethargy at least 5 days prior to admission, plus
CSF with abnormalities of at least two of these three characters;
- Lymphocytic pleocytosis (≥ 50%)
- More than 40 mg/ml of protein
- Lower than 0.5 of CSF: blood sugar ratio
Exclusion Criteria:
- Contraindicated in lumbar puncture
- Positive for cryptococcal antigen in the CSF.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Xpert
Centrifuged CSF sent for Xpert MTB/RIF
|
CSF samples was centrifuged at 3,000 - 4,000 X g for 15 minutes.
Supernatant was removed to leave a 1-ml precipitate, which was then used for Ziehl-Neelsen AFB staining (100 μl), inoculation of MGIT culture (100 μl), and Xpert MTB/RIF testing (800 μl).
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Detection of M. tuberculosis from CSF specimen
Time Frame: 2 years
|
Diagnostic values of Xpert MTB/RIF for detecting M. tuberculosis from CSF
|
2 years
|
Collaborators and Investigators
Sponsor
Publications and helpful links
General Publications
- Nhu NT, Heemskerk D, Thu do DA, Chau TT, Mai NT, Nghia HD, Loc PP, Ha DT, Merson L, Thinh TT, Day J, Chau Nv, Wolbers M, Farrar J, Caws M. Evaluation of GeneXpert MTB/RIF for diagnosis of tuberculous meningitis. J Clin Microbiol. 2014 Jan;52(1):226-33. doi: 10.1128/JCM.01834-13. Epub 2013 Nov 6.
- Marais S, Thwaites G, Schoeman JF, Torok ME, Misra UK, Prasad K, Donald PR, Wilkinson RJ, Marais BJ. Tuberculous meningitis: a uniform case definition for use in clinical research. Lancet Infect Dis. 2010 Nov;10(11):803-12. doi: 10.1016/S1473-3099(10)70138-9. Epub 2010 Sep 6.
- Marx GE, Chan ED. Tuberculous meningitis: diagnosis and treatment overview. Tuberc Res Treat. 2011;2011:798764. doi: 10.1155/2011/798764. Epub 2011 Dec 21.
- Patel VB, Theron G, Lenders L, Matinyena B, Connolly C, Singh R, Coovadia Y, Ndung'u T, Dheda K. Diagnostic accuracy of quantitative PCR (Xpert MTB/RIF) for tuberculous meningitis in a high burden setting: a prospective study. PLoS Med. 2013 Oct;10(10):e1001536. doi: 10.1371/journal.pmed.1001536. Epub 2013 Oct 22.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Central Nervous System Diseases
- Nervous System Diseases
- Infections
- Central Nervous System Infections
- Bacterial Infections
- Bacterial Infections and Mycoses
- Gram-Positive Bacterial Infections
- Actinomycetales Infections
- Mycobacterium Infections
- Meningitis, Bacterial
- Central Nervous System Bacterial Infections
- Tuberculosis, Central Nervous System
- Tuberculosis
- Meningitis
- Tuberculosis, Meningeal
Other Study ID Numbers
- CMUXpertTBM
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Tuberculous Meningitis
-
All India Institute of Medical Sciences, New DelhiRecruitingTuberculous Meningitis | Tuberculous ArachnoiditisIndia
-
Universitas PadjadjaranRadboud University Medical Center; United States Agency for International Development...CompletedTuberculosis, MeningealIndonesia
-
Hui BuUnknown
-
Universitas PadjadjaranRadboud University Medical CenterCompletedTuberculous MeningitisIndonesia
-
Xijing HospitalCompleted
-
University of StellenboschRecruitingTuberculous MeningitisSouth Africa
-
Beijing Chest HospitalRecruitingTuberculous MeningitisChina
-
Huashan HospitalUnknownTuberculous MeningitisChina
-
National Institute of Allergy and Infectious Diseases...RecruitingTuberculous MeningitisSouth Africa, Zimbabwe, India, Kenya, Malawi, Mexico, Peru, Brazil, Philippines, Tanzania, Thailand, Vietnam
-
University of OxfordWellcome TrustUnknownHIV Infections | Tuberculous MeningitisVietnam
Clinical Trials on Xpert MTB/RIF
-
University of Cape TownRadboud University Medical Center; McGill University; University of Cape Town... and other collaboratorsCompletedTuberculosisZimbabwe, South Africa, Zambia
-
University of North Carolina, Chapel HillNational Institutes of Health (NIH)Completed
-
University of North Carolina, Chapel HillCenters for Disease Control and PreventionCompleted
-
Institut National de la Santé Et de la Recherche...UNITAIDRecruiting
-
Medecins Sans Frontieres, SpainMinistry of Health, Guinea-Bissau; Institute of Tropical Medicine, University... and other collaboratorsCompletedTuberculosis | Pediatric Infectious DiseaseGuinea-Bissau, South Sudan
-
Taipei Medical University WanFang HospitalBuddhist Tzu Chi General Hospital; Taichung Veterans General Hospital; Chang-Hua... and other collaboratorsActive, not recruitingPulmonary Tuberculosis Confirmation by CultureTaiwan
-
Ataulpho de Paiva FoundationBill and Melinda Gates FoundationCompleted
-
Liverpool School of Tropical MedicineREACH Ethiopia; Bingham UniversityCompleted
-
Institut National de la Santé Et de la Recherche...UNITAIDCompletedCovid19 | Tuberculosis | Severe PneumoniaUganda, Cambodia, Cameroon, Côte D'Ivoire, Mozambique, Zambia
-
Foundation for Innovative New Diagnostics, SwitzerlandCompletedTuberculosis, PulmonaryBelarus, Georgia, India, South Africa